PDS Biotechnology(DE:EU6)
€0.79-0.01 (-1.50%)
DE:EU6
PDS Biotechnology ownership
€0.79
At close:-0.01 (-1.50%)
PDS Biotechnology (EU6) Ownership - Who Owns PDS Biotechnology?
2 Followers
PDS Biotechnology (EU6) Ownership Overview
- 0.80% Insiders
- 2.21% Mutual Funds
- 2.74% Other Institutional Investors
- 1.50% ETFs
- 92.75% Public Companies and Individual Investors
The ownership structure of PDS Biotechnology (DE:EU6) stock is a mix of institutional, retail, and individual investors. Approximately 6.45% of the company’s stock is owned by Institutional Investors, 0.80% is owned by Insiders, and 92.75% is owned by Public Companies and Individual Investors.
The ownership structure of PDS Biotechnology (DE:EU6) stock is a mix of institutional, retail, and individual investors. Approximately 6.45% of the company’s stock is owned by Institutional Investors, 0.80% is owned by Insiders, and 92.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,626,001 | Institution | 1.55% | 1,347,955 |
| Vanguard | 1,405,122 | Institution | 1.34% | 1,164,846 |
| Frank Bedu-addo | 690,866 | Insider | 0.66% | 572,728 |
| BlackRock, Inc. | 598,896 | Institution | 0.57% | 496,485 |
| Fidelity Concord Street Trust | 501,372 | Institution | 0.48% | 415,637 |
| Ishares | 173,674 | Institution | 0.17% | 143,976 |
| Tiaa-cref Funds | 105,201 | Institution | 0.10% | 87,212 |
| Steve Glover | 78,851 | Insider | 0.08% | 65,367 |
| Gregory Gene Freitag | 61,213 | Insider | 0.06% | 50,746 |
| Vanguard Institutional Index Funds | 47,619 | Institution | 0.05% | 39,476 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,626,001 | Institution | 1.55% | 1,347,955 |
| Fidelity Concord Street Trust | 501,372 | Institution | 0.48% | 415,637 |
| Tiaa-cref Funds | 105,201 | Institution | 0.10% | 87,212 |
| Vanguard Institutional Index Funds | 47,619 | Institution | 0.05% | 39,476 |
| Vanguard Valley Forge Funds | 25,695 | Institution | 0.02% | 21,301 |
| Northern Funds | 10,721 | Institution | 0.01% | 8,888 |
| Victory Portfolios Iii | 2,937 | Institution | <0.01% | 2,435 |
| Advisors' Inner Circle Iii | 278 | Institution | <0.01% | 230 |
FAQ
Who Owns PDS Biotechnology (DE:EU6)?
According to the latest TipRanks data, approximately 6.45% of the company's stock is held by institutional investors, 0.80% is held by insiders, and 92.75% is held by public companies and individual investors.
What percentage of PDS Biotechnology (DE:EU6) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.45% of PDS Biotechnology (DE:EU6) stock is held by institutional investors: 2.21% by mutual funds, 1.50% by ETFs and 2.74% by other institutional investors.
What percentage of PDS Biotechnology (DE:EU6) stock is held by retail investors?
According to the latest TipRanks data, approximately 92.75% of PDS Biotechnology (DE:EU6) stock is held by public companies and individual investors.
Who owns the most shares of PDS Biotechnology (DE:EU6)?
VANGUARD INDEX FUNDS owns the most shares of PDS Biotechnology (DE:EU6).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

